The Global Digital Health For Cardiovascular Market size is expected to reach $162.40 billion by 2031, rising at a market growth of 21.9% CAGR during the forecast period.
The North America segment witnessed 37% revenue share in the market in 2023. The region benefits from the widespread use of remote patient monitoring (RPM) devices, telemedicine platforms, and wearable health technologies like the Apple Watch and KardiaMobile, which are FDA-cleared for detecting cardiovascular conditions such as atrial fibrillation.
The global prevalence of cardiovascular diseases (CVDs) has been rising at an alarming rate, making them the leading cause of death worldwide. In 2019, the World Health Organization (WHO) estimated that 17.9 million individuals perished from cardiovascular diseases (CVDs), which accounted for 32% of all global deaths. Heart attacks and strokes were responsible for 85% of these fatalities. Hence, the rising prevalence of cardiovascular diseases globally drives demand for digital health solutions.
Additionally, Wearable devices such as smartwatches, fitness trackers, and wearable ECG monitors have grown significantly over the past decade, emerging as vital tools in proactive cardiovascular care. One of the standout examples of wearables transforming heart health is their ability to detect atrial fibrillation (AFib). AFib is a cardiac rhythm that is irregular and frequently rapid, and it can result in heart failure, stroke, blood clots, and other heart-related complications. Thus, as technology advances, these devices are expected to become an even more integral part of preventive cardiology and chronic disease management.
Moreover, The COVID-19 pandemic initially posed several challenges to the digital health for cardiovascular market. In the early stages, healthcare systems worldwide were overwhelmed by COVID-19 cases, diverting attention and resources from non-emergency cardiovascular care. Elective procedures and routine check-ups for heart patients were often delayed or canceled, disrupting the standard treatment and monitoring processes. Thus, the pandemic had an overall positive impact on the market.
However, Many healthcare providers and patients are unable to access devices such as wearable cardiac monitors, AI-powered diagnostics, and remote patient monitoring systems due to their substantial cost. These technologies often require continuous updates, software integrations, and cloud storage, increasing operational expenses. Additionally, setting up telemedicine infrastructure and maintaining digital platforms for cardiovascular patients demands investment in cybersecurity, compliance with regulations, and staff training, which can financially overwhelm healthcare institutions. Hence, without strategic interventions, the high cost of digital health tools will continue to be a significant hurdle in transforming cardiovascular healthcare through digitalization.
The leading players in the market are competing with diverse innovative offerings to remain competitive in the market. The above illustration shows the percentage of revenue shared by some of the leading companies in the market. The leading players of the market are adopting various strategies in order to cater demand coming from the different industries. The key developmental strategies in the market are Acquisitions, and Partnerships & Collaborations.
The North America segment witnessed 37% revenue share in the market in 2023. The region benefits from the widespread use of remote patient monitoring (RPM) devices, telemedicine platforms, and wearable health technologies like the Apple Watch and KardiaMobile, which are FDA-cleared for detecting cardiovascular conditions such as atrial fibrillation.
The global prevalence of cardiovascular diseases (CVDs) has been rising at an alarming rate, making them the leading cause of death worldwide. In 2019, the World Health Organization (WHO) estimated that 17.9 million individuals perished from cardiovascular diseases (CVDs), which accounted for 32% of all global deaths. Heart attacks and strokes were responsible for 85% of these fatalities. Hence, the rising prevalence of cardiovascular diseases globally drives demand for digital health solutions.
Additionally, Wearable devices such as smartwatches, fitness trackers, and wearable ECG monitors have grown significantly over the past decade, emerging as vital tools in proactive cardiovascular care. One of the standout examples of wearables transforming heart health is their ability to detect atrial fibrillation (AFib). AFib is a cardiac rhythm that is irregular and frequently rapid, and it can result in heart failure, stroke, blood clots, and other heart-related complications. Thus, as technology advances, these devices are expected to become an even more integral part of preventive cardiology and chronic disease management.
Moreover, The COVID-19 pandemic initially posed several challenges to the digital health for cardiovascular market. In the early stages, healthcare systems worldwide were overwhelmed by COVID-19 cases, diverting attention and resources from non-emergency cardiovascular care. Elective procedures and routine check-ups for heart patients were often delayed or canceled, disrupting the standard treatment and monitoring processes. Thus, the pandemic had an overall positive impact on the market.
However, Many healthcare providers and patients are unable to access devices such as wearable cardiac monitors, AI-powered diagnostics, and remote patient monitoring systems due to their substantial cost. These technologies often require continuous updates, software integrations, and cloud storage, increasing operational expenses. Additionally, setting up telemedicine infrastructure and maintaining digital platforms for cardiovascular patients demands investment in cybersecurity, compliance with regulations, and staff training, which can financially overwhelm healthcare institutions. Hence, without strategic interventions, the high cost of digital health tools will continue to be a significant hurdle in transforming cardiovascular healthcare through digitalization.
The leading players in the market are competing with diverse innovative offerings to remain competitive in the market. The above illustration shows the percentage of revenue shared by some of the leading companies in the market. The leading players of the market are adopting various strategies in order to cater demand coming from the different industries. The key developmental strategies in the market are Acquisitions, and Partnerships & Collaborations.
Driving and Restraining Factors
Drivers
- Rising Prevalence of Cardiovascular Diseases (CVDs)
- Growing Adoption of Wearable Devices
- Increased Demand for Remote Patient Monitoring (RPM)
Restraints
- High Cost of Advanced Digital Health Tools
- Limited Digital Literacy Among Patients and Healthcare Professionals
Opportunities
- Technological Advancements in Telehealth
- Increasing Proportion of the Aging Population
Challenges
- Regulatory and Reimbursement Challenges
- Significant Data Privacy and Security Concerns
End use Outlook
On the basis of end-use, the market is divided into patients, providers, payers, and others. The providers segment recorded 21% revenue share in the market in 2023. Hospitals, clinics, and cardiac centers are increasingly adopting digital health tools such as telemedicine platforms, remote patient monitoring systems, and AI-powered diagnostic solutions to provide timely and accurate cardiovascular care.
Component Outlook
Based on component, the market is classified into software, hardware, and services. The hardware segment procured 29% revenue share in the market in 2023. The demand for devices such as ECG monitors, smartwatches with heart rate sensors, and implantable cardiac devices has increased as a result of the increasing prevalence of heart diseases as well as the growing emphasis on preventive care.Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment garnered 24% revenue share in the market in 2023. Rapid urbanization, changing dietary habits, sedentary lifestyles, and high rates of hypertension and diabetes have increased the demand for digital health solutions targeting heart disease prevention and management.Recent Strategies Deployed in the Market
- Feb-2025: Apple, Inc. launched the Apple Health Study to explore connections between physical and mental health, including cardiovascular and circulatory health. The study, conducted in partnership with Brigham and Women’s Hospital, a Harvard Medical School affiliate, will leverage data from iPhones, Apple Watches, and AirPods over five years. This initiative builds on Apple’s previous research, such as the Apple Heart Study, which contributed to health-monitoring features in its devices, further advancing digital health innovation.
- Sep-2024: Cleerly, Inc. formed a partnership with Viz.ai, a U.S.-based AI healthcare company, to integrate AI-driven cardiovascular diagnostics into the Viz.ai One platform. This partnership aims to enhance early detection and care coordination for heart disease by leveraging Cleerly’s FDA-approved AI software for analyzing coronary CTA images. By automating ischemia detection and plaque quantification, the collaboration seeks to improve patient outcomes through timely specialist referrals and personalized treatment planning.
- Oct-2023: GE HealthCare came into partnership with Caption Health, a U.S.-based AI healthcare company, to integrate AI-driven Caption Guidance into its Venue Family point-of-care ultrasound systems. This AI-powered tool provides real-time guidance for cardiac ultrasound imaging, enabling a wider range of healthcare providers to conduct scans with diagnostic accuracy. The integration aims to enhance early heart disease detection, improve clinical decision-making, and expand ultrasound access in emergency and critical care settings.
- Aug-2023: GE HealthCare Technologies, Inc. launched CardioVisio for Atrial Fibrillation, a digital clinical decision support tool designed to enhance precision care for AFib patients. This AI-powered solution integrates longitudinal patient data from multiple sources, providing guideline-directed insights to clinicians. By streamlining image interpretation and aiding treatment decisions, CardioVisio aims to improve patient outcomes and reduce misdiagnoses.
- Aug-2022: GE HealthCare partnered with Nex Cubed, a U.S.-based startup accelerator, to launch the Edison Accelerator in Canada, selecting six AI-driven digital health startups to enhance medical imaging. This program aims to integrate AI into clinical workflows, improving diagnostics in areas like bone density screening, prostate cancer detection, and cardiac imaging.
List of Key Companies Profiled
- Apple, Inc.
- Orange S.A.
- Epic Systems Corporation
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- CardiAI.Inc
- Vista.ai (HeartVista, Inc.)
- Viz.ai, Inc.
- Cleerly, Inc.
- RSIP Vision Ltd.
Market Report Segmentation
By Component
- Services
- Software
- Hardware
By End-use
- Patients
- Providers
- Payers
- Other End-use
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Global Digital Health For Cardiovascular Market by Component
Chapter 6. Global Digital Health For Cardiovascular Market by End-use
Chapter 7. Global Digital Health For Cardiovascular Market by Region
Chapter 8. Company Profiles
Companies Mentioned
- Apple, Inc.
- Orange S.A.
- Epic Systems Corporation
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- CardiAI.Inc
- Vista.ai (HeartVista, Inc.)
- Viz.ai, Inc.
- Cleerly, Inc.
- RSIP Vision Ltd.
Methodology
LOADING...
